PER 0.00% 7.9¢ percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,710 Posts.
    lightbulb Created with Sketch. 1097
    Great news.

    Now for the cornerstone partner.

    Way too early to sell the farm...but you just never know how desperate Big Pharma is for pipeline, considering ATL has potential beyond just DMD.

    Now the tox study is complete, wonder if the MS program gets dusted off too?

    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
0.000(0.00%)
Mkt cap ! $82.42M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $50.80K 635.9K

Buyers (Bids)

No. Vol. Price($)
8 618776 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 195070 6
View Market Depth
Last trade - 11.55am 07/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.